Healthcare

Converge Bio

Generative AI platform for drug target discovery and antibody design

Visit Converge Bio
1 viewsPricing · PaidRising
The Falcoscan Intel Panel/Converge Bio · Healthcare
Live market data
Opportunity
84
Strong/ 100
Saturation
11
Open/ 100
Wrapper Risk
9
Open/ 100
Signal
Rising
Market trend
The Brief

What Converge Bio does

Converge Bio combines proprietary generative AI models into an end-to-end system for drug discovery, giving biologists actionable outputs such as novel drug targets, optimized antibody candidates, and manufacturing-ready protein sequences without writing code. Founded in 2024 by CEO Dov Gertz, CSO Iddo Weiner, and CTO Oded Kalev, the Israeli-founded company says more than a dozen pharma and biotech partners use its platform, and that it has discovered antibodies with single-digit nanomolar binding affinities and improved protein manufacturing yields by 4-7x.

Builder’s Brief

Converge Bio is a healthcare tool on Falcoscan. Generative AI platform for drug target discovery and antibody design. Falcoscan rates Converge Bio with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Converge Bio is founded in 2024, currently at Series_a stage. Pricing: Paid.

Market position · Healthcare

How Converge Bio compares in Healthcare

Converge Bio's opportunity score of 84 ranks #41 of 137 live Healthcare tools on Falcoscan, 2.2 points above the category average of 81.8. Its saturation score is 11/100, against a category average of 11. 75 of the 137 live Healthcare tools carry a hot signal, and Falcoscan has recorded 8 shutdowns in the category.

Converge Bio compared with top-rated Healthcare tools
ProductOpportunitySaturationPricingSignal
Converge Bio8411PaidRising
DeepMind AlphaFold886FreeHot
Nuance DAX Copilot9012PaidHot
Viz.ai AI Stroke Response906PaidHot
Tempus AI Diagnostics886PaidHot
Viz.ai Stroke AI888PaidHot
What it ships with

Capabilities & who uses it

The capabilities Converge Bio exposes to builders and the verticals it currently serves.

AI Capabilities
Target DiscoveryAntibody DesignProtein OptimizationGenerative Molecule Design
Industry Verticals
HealthcareBiotechPharmaceuticals
Tagged

Converge Bio shows up when builders search for these

drug-discoverygenerative-aiantibody-designprotein-engineeringbiotech
Similar tools · Healthcare

Alternatives to Converge Bio

The top-rated live healthcare tools tracked on Falcoscan, ranked by Falcoscan rating within the category.

See the Healthcare market
Healthcare
DeepMind AlphaFold

AI protein structure prediction for drug discovery

★ 4.9Opp 88
Free
Healthcare
Nuance DAX Copilot

AI clinical documentation assistant for physicians

★ 4.8Opp 90
Paid
Healthcare
Viz.ai AI Stroke Response

AI stroke detection and care coordination platform

★ 4.8Opp 90
Paid
Healthcare
Tempus AI Diagnostics

AI liquid biopsy analysis for early cancer detection

★ 4.8Opp 88
Paid
Healthcare
Viz.ai Stroke AI

AI triage and coordination platform for stroke care

★ 4.8Opp 88
Paid
Healthcare
Anterior AI Insurance

AI prior authorization automation for health insurance

★ 4.7Opp 88
Paid
Questions

Converge Bio: common questions

Is Converge Bio free?

No. Converge Bio is a paid product.

What are the best alternatives to Converge Bio?

The top-rated live Healthcare tools on Falcoscan, other than Converge Bio, are DeepMind AlphaFold, Nuance DAX Copilot, Viz.ai AI Stroke Response, Tempus AI Diagnostics, and Viz.ai Stroke AI.

Is Converge Bio still operating?

Yes. Falcoscan's operating checks list Converge Bio as active.

Where is Converge Bio based?

Converge Bio is headquartered in Boston, United States.

Does Converge Bio have an API?

Falcoscan's records show no public API for Converge Bio.

Who is Converge Bio for?

Converge Bio is built for pharmaceutical companies, biotech companies, and researchers.

Back to Browse